FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Sachs Adam David 2. Issuer Name and Ticker or Trading Symbol Vicarious Surgical Inc. [ RBOT ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President and CEO
(Last)          (First)          (Middle)
C/O VICARIOUS SURGICAL INC., 78 FOURTH AVENUE		 3. Date of Earliest Transaction (MM/DD/YYYY)
11/28/2022
(Street)
WALTHAM, MA 02451
(City)        (State)        (Zip)
 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock  11/28/2022    C    11329  A  (1) 1254121  D   
Class A Common Stock  11/28/2022    S(2)    11329  D $3.43 (3) 1242792  D   
Class A Common Stock  11/28/2022    S(4)    8325  D $3.45 (5) 1234467  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Common Stock   (1) 9/27/2022    C        11329    (1)  (1) Class A Common Stock  11329  $0  11239063  D   

Explanation of Responses:
(1)  Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.
(2)  These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.
(3)  This figure is the weighted average sales price of multiple trades ranging from $3.37 to $3.48 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
(4)  These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.
(5)  This figure is the weighted average sales price of multiple trades ranging from $3.36 to $3.62 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Sachs Adam David
C/O VICARIOUS SURGICAL INC.
78 FOURTH AVENUE
WALTHAM, MA 02451		 X
President and CEO

Signatures
/s/ June Morris, Attorney-in-Fact 11/30/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
D8 (NYSE:DEH)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more D8 Charts.
D8 (NYSE:DEH)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more D8 Charts.